Compounds > cytarabine

cytarabine and Pyoderma Gangrenosum

cytarabine has been researched along with Pyoderma Gangrenosum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bozoglan, H; Ergene, U; Yoleri, L1
Kusama, H; Matsuoka, T; Ohsaka, A; Taguchi, H; Takagi, S1

Other Studies

2 other study(ies) available for cytarabine and Pyoderma Gangrenosum

ArticleYear
Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2011, Volume: 45, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Pancytopenia; Pyoderma Gangrenosum; Wound Healing

2011
Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndrome.
    Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:3

    Topics: Aclarubicin; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Biopsy; Cytarabine; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Male; Myelodysplastic Syndromes; Prednisolone; Pyoderma Gangrenosum; Recurrence; Skin

1998